A detailed history of Portolan Capital Management, LLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 1,224,020 shares of CLBT stock, worth $27.6 Million. This represents 1.64% of its overall portfolio holdings.

Number of Shares
1,224,020
Previous 1,020,952 19.89%
Holding current value
$27.6 Million
Previous $12.2 Million 68.95%
% of portfolio
1.64%
Previous 1.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.61 - $17.52 $2.36 Million - $3.56 Million
203,068 Added 19.89%
1,224,020 $20.6 Million
Q2 2024

Aug 14, 2024

SELL
$10.38 - $12.5 $1.27 Million - $1.53 Million
-122,720 Reduced 10.73%
1,020,952 $12.2 Million
Q1 2024

May 15, 2024

BUY
$8.04 - $12.29 $9.2 Million - $14.1 Million
1,143,672 New
1,143,672 $12.7 Million

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $4.27B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.